You can also contribute to the European Committee for Advanced Therapies (CAT)

Yes the European Medicines Agency (EMA) is calling for interested parties to express their interest in participating in the activities of the Committee for Advanced Therapies (CAT). Successful applicants will be added to the list of interested parties to CAT.

CAT engages in active dialogue with its stakeholders in the field of advanced therapies, including industry, developers of medicines, academia, patients and clinicians.

This allows the exchange of scientific views and the further development of the regulatory framework for the authorisation of advanced-therapy medicinal products (ATMPs). The Committee recognises the importance of dialogue and working relationships with its interested parties, in order to implement the ATMP legislation successfully.

So if your organisation works in the field of advanced therapies, this is their chance to get involved and make their views known.